We are live on
!
Find out more
SCM
Scopia Capital Management Portfolio holdings
AUM
$112M
1-Year Est. Return
48.41%
This Fund
S&P 500
This Quarter
Est. Return
+14.89%
1 Year Est. Return
+48.41%
3 Year Est. Return
+58.7%
5 Year Est. Return
+80.15%
10 Year Est. Return
+533.22%
AUM
$4.62B
AUM Growth
-$744M
(-14%)
Cap. Flow
-$43.2M
Cap. Flow
% of AUM
-0.93%
Top 10 Holdings %
Top 10 Hldgs %
72.44%
Holding
37
New
7
Increased
10
Reduced
10
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VMW
VMware, Inc
VMW
|
+$142M |
| 2 |
Huntsman Corp
HUN
|
+$140M |
| 3 |
FCE.A
Forest City Realty Trust, Inc.
FCE.A
|
+$58.7M |
| 4 |
Myriad Genetics
MYGN
|
+$58.5M |
| 5 |
Brookdale Senior Living
BKD
|
+$47.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$192M |
| 2 |
AutoNation
AN
|
+$139M |
| 3 |
United Therapeutics
UTHR
|
+$82.6M |
| 4 |
Darling Ingredients
DAR
|
+$59.3M |
| 5 |
MLNX
Mellanox Technologies, Ltd.
MLNX
|
+$52.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 27.08% |
| 2 | Healthcare | 26.51% |
| 3 | Miscellaneous | 19.36% |
| 4 | Communication Services | 9.18% |
| 5 | Real Estate | 6.55% |
Similar funds
SWM
TFS
WAM
CS
BU
TBFA
VDC
RQS
Scopia Capital Management's Q1 2015 Portfolio in Review
As of Q1 2015, Scopia Capital Management held 37 positions worth $4.62B, down 14% from $5.37B the previous quarter. Its ten largest holdings account for 72% of the portfolio.
Scopia Capital Management's Q1 2015 filing shows 7 new, 10 increased, 10 reduced and 7 closed positions. Its largest new stake was VMware, Inc: 1,731,727 shares worth $142M. The largest sale was Teva Pharmaceuticals, an estimated $192M.
By sector, the portfolio is most concentrated in Industrials at 27% of assets, up from 19% a quarter earlier, followed by Healthcare and Miscellaneous.
- Scopia Capital Management's largest Q1 2015 buy was VMware, Inc: 1,731,727 shares worth $142M.
- Scopia Capital Management added most to Forest City Realty Trust, Inc. in Q1 2015, an estimated $58.7M increase.
- Scopia Capital Management's biggest Q1 2015 reduction was United Therapeutics, cutting an estimated $82.6M.
- Scopia Capital Management fully exited Teva Pharmaceuticals in Q1 2015, selling an estimated $192M.
- Scopia Capital Management's ten largest holdings make up 72% of its $4.62B portfolio in Q1 2015.
- Scopia Capital Management opened 7 new positions and closed 7 in Q1 2015.
- Scopia Capital Management's portfolio value fell 14% quarter-over-quarter to $4.62B.
Based on Scopia Capital Management's 13F filing for Q1 2015, filed 15 May 2015.